RecruitingNCT02688894
The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]
Studying Embryonal carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Samsung Medical Center
- Principal Investigator
- Se-Hoon Lee, MD, PhDSamsung Medical Center
- Intervention
- No treatment is included in this protocol.(other)
- Enrollment
- 797 target
- Eligibility
- 20 years · All sexes
- Timeline
- 2016 – 2028
Study locations (6)
- Gachon University Gil Medical Center, Incheon, South Korea
- Chungbuk University Hospital, Jungbuk, South Korea
- Seoul National University Bundang Hospital, Seongnam, South Korea
- Samsung Medical Center, Seoul, South Korea
- VHS Medical Center, Seoul, South Korea
- Ulsan University Hospital, Ulsan, South Korea
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02688894 on ClinicalTrials.govOther trials for Embryonal carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT04086485Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)National Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGNCT05168631Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine TumorsLatin American Cooperative Oncology Group
- RECRUITINGPHASE1, PHASE2NCT02174549Dose-defining Study of Tirapazamine Combined With Embolization in Liver CancerTeclison Ltd.
- RECRUITINGNANCT01980264Harmonics-based in Vivo Optical Virtual BiopsyNational Taiwan University Hospital